Reduced serum chemerin in patients with more severe liver cirrhosis

被引：25

作者：

Eisinger, Kristina ^{[1
]}

Krautbauer, Sabrina ^{[1
]}

Wiest, Reiner ^{[2
]}

Weiss, Thomas S. ^{[3
]}

Buechler, Christa ^{[1
]}

机构：

[1] Regensburg Univ Hosp, Dept Internal Med 1, D-93042 Regensburg, Germany

[2] Univ Inselspital, Dept Visceral Surg & Med, Bern, Switzerland

[3] Regensburg Univ Hosp, Dept Pediat & Juvenile Med, D-93042 Regensburg, Germany

来源：

EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2015年 / 98卷 / 02期

关键词：

Portal vein; CHILD-PUGH stage; Adipokine; Portal hypertension; NONALCOHOLIC STEATOHEPATITIS; PATHOPHYSIOLOGY; COMPLICATIONS; INFLAMMATION; HYPERTENSION; EXPRESSION; PROGNOSIS; GRADIENT; OMENTIN; OBESITY;

D O I：

10.1016/j.yexmp.2015.01.010

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Chemerin is a well-established modulator of immune cell function and its serum levels are induced in inflammatory diseases. Liver cirrhosis is associated with inflammation which is aggravated by portal hypertension. The objective of this study was to evaluate whether chemerin is induced in patients with more severe liver cirrhosis and portal hypertension. Chemerin has been measured by ELISA in the portal venous serum (PVS), systemic venous serum (SVS) and hepatic venous serum (HVS) of 45 patients with liver cirrhosis. Chemerin is higher in HVS compared to PVS in accordance with our recently published finding. SVS, HVS and PVS chemerin decline in patients with more advanced liver injury defined by the CHILD-PUGH score. Hepatic chemerin has been determined in a small cohort and is similarly expressed in normal and cirrhotic liver. MELD score and serum markers of liver and kidney function do not correlate with chemerin. There is a positive correlation of chemerin in all compartments with Quick prothrombin time and of SVS chemerin with systolic blood pressure. PVS chemerin is induced in patients with modest/massive ascites but this does not translate into higher HVS and SVS levels. Chemerin is not associated with variceal size. Reduction of portal pressure by transjugular intrahepatic portosystemic shunt does not affect chemerin levels. These data show that low chemerin in patients with more severe liver cirrhosis is associated with reduced Quick prothrombin time. (C) 2015 Elsevier Inc. All rights reserved.

引用

页码：208 / 213

页数：6

共 37 条

[1] Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt [J].

Angermayr, B ;

Cejna, M ;

Karnel, F ;

Gschwantler, M ;

Koenig, F ;

Pidlich, J ;

Mendel, H ;

Pichler, L ;

Wichlas, M ;

Kreil, A ;

Schmid, M ;

Ferlitsch, A ;

Lipinski, E ;

Brunner, H ;

Lammer, J ;

Ferenci, P ;

Gangl, A ;

Peck-Radosavljevic, M .

GUT, 2003, 52 (06) :879-885

[2] Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury [J].

Bauer, Sabrina ;

Eisinger, Kristina ;

Wiest, Reiner ;

Karrasch, Thomas ;

Scherer, Marcus N. ;

Farkas, Stefan ;

Aslanidis, Charalampos ;

Buechler, Christa .

REGULATORY PEPTIDES, 2012, 179 (1-3) :10-14

[3] Sterol Regulatory Element-Binding Protein 2 (SREBP2) Activation after Excess Triglyceride Storage Induces Chemerin in Hypertrophic Adipocytes [J].

Bauer, Sabrina ;

Wanninger, Josef ;

Schmidhofer, Sandra ;

Weigert, Johanna ;

Neumeier, Markus ;

Dorn, Christoph ;

Hellerbrand, Claus ;

Zimara, Nicole ;

Schaeffler, Andreas ;

Aslanidis, Charalampos ;

Buechler, Christa .

ENDOCRINOLOGY, 2011, 152 (01) :26-35

[4] The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS) [J].

Benten, Daniel ;

zur Wiesch, Julian Schulze ;

Sydow, Karsten ;

Koops, Andreas ;

Buggisch, Peter ;

Boeger, Rainer H. ;

Gaydos, Charlotte A. ;

Won, Helen ;

Franco, Veronica ;

Lohse, Ansgar W. ;

Ray, Stuart C. ;

Balagopal, Ashwin .

BMC GASTROENTEROLOGY, 2011, 11

[5] MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study [J].

Botta, F ;

Giannini, E ;

Romagnoli, P ;

Fasoli, A ;

Malfatti, F ;

Testa, E ;

Risso, D ;

Colla, G ;

Testa, R .

GUT, 2003, 52 (01) :134-139

[6] Adiponectin, a key adipokine in obesity related liver diseases [J].

Buechler, Christa ;

Wanninger, Josef ;

Neumeier, Markus .

WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (23) :2801-2811

[7] Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease [J].

Doecke, S. ;

Lock, J. F. ;

Birkenfeld, A. L. ;

Hoppe, S. ;

Lieske, S. ;

Rieger, A. ;

Raschzok, N. ;

Sauer, I. M. ;

Florian, S. ;

Osterhoff, M. A. ;

Heller, R. ;

Herrmann, K. ;

Lindenmueller, S. ;

Horn, P. ;

Bauer, M. ;

Weickert, M. O. ;

Neuhaus, P. ;

Stockmann, M. ;

Moehlig, M. ;

Pfeiffer, A. F. H. ;

von Loeffelholz, C. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (05) :547-557

[8] Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension [J].

Eisinger, Kristina ;

Krautbauer, Sabrina ;

Wiest, Reiner ;

Karrasch, Thomas ;

Hader, Yvonne ;

Scherer, Marcus N. ;

Farkas, Stefan ;

Aslanidis, Charalampos ;

Buechler, Christa .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (09) :926-932

[9] Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab [J].

Gisondi, P. ;

Lora, V. ;

Bonauguri, C. ;

Russo, A. ;

Lippi, G. ;

Girolomoni, G. .

BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (04) :749-755

[10] Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice [J].

Gruben, Nanda ;

Vergara, Marcela Aparicio ;

Kloosterhuis, Niels J. ;

van der Molen, Henk ;

Stoelwinder, Stefan ;

Youssef, Sameh ;

de Bruin, Alain ;

Delsing, Dianne J. ;

Kuivenhoven, Jan Albert ;

van de Sluis, Bart ;

Hofker, Marten H. ;

Koonen, Debby P. Y. .

PLOS ONE, 2014, 9 (04)

← 1 2 3 4 →